0001654954-24-004605.txt : 20240415 0001654954-24-004605.hdr.sgml : 20240415 20240415114325 ACCESSION NUMBER: 0001654954-24-004605 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240415 FILED AS OF DATE: 20240415 DATE AS OF CHANGE: 20240415 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INDIVIOR PLC CENTRAL INDEX KEY: 0001625297 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37835 FILM NUMBER: 24843632 BUSINESS ADDRESS: STREET 1: 234 BATH ROAD CITY: SLOUGH, BERKSHIRE STATE: X0 ZIP: SL1 4EE BUSINESS PHONE: 804-379-1090 MAIL ADDRESS: STREET 1: 234 BATH ROAD CITY: SLOUGH, BERKSHIRE STATE: X0 ZIP: SL1 4EE 6-K 1 a6749k.htm HOLDING(S) IN COMPANY a6749k

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
________________________
 
Washington, D.C. 20549
_____________________
 
FORM 6-K
_____________________
 
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
 
Date: April 15, 2024
Commission File Number: 001-37835
________________________________________
 
Indivior PLC
________________________________________
 
10710 Midlothian Turnpike, Suite 125
North Chesterfield, Virginia 23235
 
(Address of principal executive office)
 
_______________________________
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F
 
Form 20-F ☒ Form 40-F ☐
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
 
 
 
 
 
 
 
 
 
 
EXHIBIT INDEX
 
 
 
 
 
 
 
 
SIGNATURES
 
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
 
 
Indivior PLC
 
Date: April 15, 2024
/s/ Kathryn Hudson
 
Name: Kathryn Hudson
 
Title: Company Secretary
 
 
 EX-99 2 a6749k-1.htm EXHIBIT 99.1 a6749k-1
Exhibit 99.1
 
 
 
TR-1: Standard form for notification of major holdings
 
1. Issuer Details
 
ISIN
GB00BN4HT335
 
Issuer Name
INDIVIOR PLC
 
UK or Non-UK Issuer
UK
 
2. Reason for Notification
An acquisition or disposal of voting rights
 
3. Details of person subject to the notification obligation
Name
Societe Generale
 
City of registered office (if applicable)
London
 
Country of registered office (if applicable)
United Kingdom
 
4. Details of the shareholder
Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above
 
 
City of registered office (if applicable)
 
 
Country of registered office (if applicable)
 
 
5. Date on which the threshold was crossed or reached
12-Apr-2024
 
6. Date on which Issuer notified
15-Apr-2024
 
7. Total positions of person(s) subject to the notification obligation
 
% of voting rights attached to shares (total of 8.A)
% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B)
Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached
 
4.776900
 
0.000100
 
4.777000
 
6481414
 
Position of previous notification (if applicable)
 
5.768700
 
0.000100
 
5.768800
 
 
 
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible)
Number of direct voting rights (DTR5.1)
Number of indirect voting rights (DTR5.2.1)
% of direct voting rights (DTR5.1)
% of indirect voting rights (DTR5.2.1)
GB00BN4HT335
 
6481341
 
 
4.776900
 
 
Sub Total 8.A
6481341
 
4.776900%
 
 
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrument
Expiration date
Exercise/conversion period
Number of voting rights that may be acquired if the instrument is exercised/converted
% of voting rights
 
 
 
 
 
Sub Total 8.B1
 
 
 
 
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Type of financial instrument
Expiration date
Exercise/conversion period
Physical or cash settlement
Number of voting rights
% of voting rights
Contract for Difference
 
 
 
Cash
 
73
 
0.000100
 
Sub Total 8.B2
 
73
 
0.000100%
 
 
9. Information in relation to the person subject to the notification obligation
1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.
 
Ultimate controlling person
Name of controlled undertaking
% of voting rights if it equals or is higher than the notifiable threshold
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold
Total of both if it equals or is higher than the notifiable threshold
 
 
 
 
 
 
10. In case of proxy voting
Name of the proxy holder
 
 
The number and % of voting rights held
 
 
The date until which the voting rights will be held
 
 
11. Additional Information
 
 
12. Date of Completion
15-Apr-2024
 
13. Place Of Completion
London, United Kingdom